Clinical Trials Directory

Trials / Completed

CompletedNCT06513728

Pilot Study of Methadone Patient Access to Collaborative Treatment: a HEAL Initiative

Methadone Patient Access to Collaborative Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Examine the preliminary effect of the MPACT intervention on methadone treatment retention, in treatment overdose and patient trauma symptoms. The study will also explore the relationship between staff trauma symptoms and MPACT implementation.

Detailed description

Specific AIMS: AIM 1: Develop MPACT through multilevel, iterative planning with OTP staff and people with recent MMT experience. AIM 2: Conduct a 4-month MPACT pilot test in two AZ OTPs: Mesa (urban) with 50 patients and 22 staff, and Sierra Vista (rural-serving) with 50 patients and 8 staff to: 1. Determine MPACT implementation feasibility, acceptability, and preliminary effect on MMT practice change and culture. 2. Determine MPACT preliminary effect on MMT retention, in-MMT overdose, and patient PTSS. 3. Characterize staff trauma history, PTSS and vicarious trauma, and explore their relationship with MPACT acceptability and implementation fidelity. AIM 3: Characterize MPACT acceptability, likely adoption, and recruitment feasibility among directors, case managers and counselors from a national random sample of 500 OTPs.

Conditions

Interventions

TypeNameDescription
OTHERMPACT InterventionMPACT has 4 components: accredited training about patient centered, trauma informed methadone treatment, staff education about trauma symptoms with navigation to self screening and treatment or stress management, clinic self assessment tools for trauma informed, patient centered care, and reflective supervision for counselors, case managers and peer staff.

Timeline

Start date
2024-09-26
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2024-07-22
Last updated
2025-08-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06513728. Inclusion in this directory is not an endorsement.